PT - JOURNAL ARTICLE AU - Yuan, Shuai AU - Li, Yuying AU - Wang, Lijuan AU - Xu, Fengzhe AU - Chen, Jie AU - Levin, Michael G AU - Xiong, Ying AU - Voight, Benjamin F. AU - Damrauer, Scott M AU - Gill, Dipender AU - Burgess, Stephen AU - Åkesson, Agneta AU - Michaëlsson, Karl AU - Li, Xue AU - Shen, Xia AU - Larsson, Susanna C. TI - Deciphering the genetic architecture of atrial fibrillation offers insights into disease prediction, pathophysiology and downstream sequelae AID - 10.1101/2023.07.20.23292938 DP - 2023 Jan 01 TA - medRxiv PG - 2023.07.20.23292938 4099 - http://medrxiv.org/content/early/2023/07/25/2023.07.20.23292938.short 4100 - http://medrxiv.org/content/early/2023/07/25/2023.07.20.23292938.full AB - Aims The study aimed to discover novel genetic loci for atrial fibrillation (AF), explore the shared genetic etiologies between AF and other cardiovascular and cardiometabolic traits, and uncover AF pathogenesis using Mendelian randomization analysis.Methods and results We conducted a genome-wide association study meta-analysis including 109,787 AF cases and 1,165,920 controls of European ancestry and identified 215 loci, among which 91 were novel. We performed Genomic Structural Equation Modeling analysis between AF and four cardiovascular comorbidities (coronary artery disease, ischemic stroke, heart failure, and vneous thromboembolism) and found 189 loci shared across these diseases as well as a universal genetic locus shared by atherosclerotic outcomes (i.e., rs1537373 near CDKN2B). Three genetic loci (rs10740129 near JMJD1C, rs2370982 near NRXN3, and rs9931494 near FTO) were associated with AF and cardiometabolic traits. A polygenic risk score derived from this genome-wide meta-analysis was associated with AF risk (odds ratio 2.36, 95% confidence interval 2.31-2.41 per standard deviation increase) in the UK biobank. This score, combined with age, sex, and basic clinical features, predicted AF risk (AUC 0.784, 95% CI 0.781-0.787) in Europeans. Phenome-wide association analysis of the polygenic risk score identified many AF-related comorbidities of the circulatory, endocrine, and respiratory systems. Phenome-wide and multi-omic Mendelian randomization analyses identified associations of blood lipids and pressure, diabetes, insomnia, obesity, short sleep, and smoking, 27 blood proteins, one gut microbe (genus.Catenibacterium), and 11 blood metabolites with risk to AF.Conclusions This genome-wide association study and trans-omic Mendelian randomization analysis provides insights into disease risk prediction, pathophysiology and downstream sequelae.Competing Interest StatementThe authors have declared no competing interest.Funding StatementFunding for this study came from the Karolinska Institutet Research Foundation Grants (Grant number 2020-01842), the Swedish Research Council (Vetenskapsradet; Grant Number 2019-00977), the Swedish Research Council for Health, Working Life and Welfare (Forte; 2018-00123) and the Swedish Heart-Lung Foundation (Hjart-Lungfonden; Grant number 20190247). Y. L. was supported by the Swedish Research Council grant (2022-01309) to X.S. X.S. also received support from a National Natural Science Foundation of China (NSFC) grant (No. 12171495), a Natural Science Foundation of Guangdong Province grant (No. 2021A1515010866), and a National Key Research and Development Program grant (No. 2022YFF1202105). DG is supported by the British Heart Foundation Centre of Research Excellence (RE/18/4/34215) at Imperial College. M.G.L. is supported by the Institute for Translational Medicine and Therapeutics of the Perelman School of Medicine at the University of Pennsylvania, the NIH/NHLBI National Research Service Award postdoctoral fellowship (T32HL007843), and the Measey Foundation.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The UK Biobank received approval from the North West-Haydock Research Ethics Committee (REC reference: 21/NW/0157), and all participants provided electronic consent. This research was conducted using the UK Biobank study under application Number 66354. We got an ethical permit from The Swedish Ethical Review Authority (2019-02793)for using SIMPLER cohorts data. Other used sources were publicly available. Ethical committees had approved all studies, and participants had signed informed consent forms.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.Yes